Heterozygous BRCA1 SNPs in the Central Functional Region are Associated With Increased Sensitivity to PARP Inhibition in Breast Cancer Cells
Clinical Breast Cancer · 2026-08 · 26 (8) · 121-130
DOI: 10.1016/j.clbc.2026.06.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-08. Verfasst von Ming-Hsin Yeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan; College of Medicine, Institute of Medici…. Hauptthemen laut MEDLINE: Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Piperazines, Phthalazines. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Breast Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan; College of Medicine, Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Electronic addres…
- College of Engineering Bioscience, National Yang Ming Chiao Tung University, Hsinchu City, Taiwan.
- AllBio Life, Inc., Taichung, Taiwan.
Zitieren
APA
Yeh, M. H., Li, C. W., Chen, L., Shih, T. Y., Kang, Y. C., & Chang, Y. D. (2026). Heterozygous BRCA1 SNPs in the Central Functional Region are Associated With Increased Sensitivity to PARP Inhibition in Breast Cancer Cells. Clinical Breast Cancer, 26(8), 121-130. https://doi.org/10.1016/j.clbc.2026.06.016
Vancouver
Yeh MH, Li CW, Chen L, Shih TY, Kang YC, Chang YD. Heterozygous BRCA1 SNPs in the Central Functional Region are Associated With Increased Sensitivity to PARP Inhibition in Breast Cancer Cells. Clinical Breast Cancer. 2026;26(8):121-130. doi:10.1016/j.clbc.2026.06.016
BibTeX
@article{Yeh2026,
author = {Yeh, Ming-Hsin and Li, Chang-Wei and Chen, Ling and Shih, Ting-Ying and Kang, Ya-Chi and Chang, Yu-Di},
title = {Heterozygous BRCA1 SNPs in the Central Functional Region are Associated With Increased Sensitivity to PARP Inhibition in Breast Cancer Cells},
journal = {Clinical Breast Cancer},
year = {2026},
volume = {26},
number = {8},
pages = {121--130},
doi = {10.1016/j.clbc.2026.06.016}
}
EUVIMED